1. |
Higgins JP,Greens.Cochrane Handbook for Systematic Reviews of Intervention (Version 5.1.0).Available at:http://www.cochrane-handbook.org.
|
2. |
Budde K,Curtis J,Knoll G,et al.Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients:results of a 1-year study.Am J Transplant,2004,4(2):237-243.
|
3. |
Ciancio G,Gaynor JJ,Zarak A,et al.Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance:four-year analysis.Transplantation,2011,91(11):1198-1205.
|
4. |
Ciancio G,Burke GW,Gaynor JJ,et al.Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin:One year follow-up.Transplantation,2008,86(1):67-74.
|
5. |
Ortega F,Sanchez-Fructuoso A,Cruzado JM,et al.Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents:mycophenolate mofetil and enteric-coated mycophenolate sodium.Transplantation,2011,92(4):426-432.
|
6. |
Langone AJ,Chan L,Bolin P,et al.Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance:a multicenter,double-blind,randomized study.Transplantation,2011,91(4):470-478.
|
7. |
Salvadori M,Holzer H,de Mattos A,et al.Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.Am J Transplantation,2004,4(2):231-236.
|
8. |
Granger DK.Enteric-coated mycophenolate sodium:results of two pivotal global multicenter trials.Transplantation Proc,2001,33(7-8):3241-3244.
|
9. |
Salvadori M.Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients.Transplantation Proc,2001,33(7-8):3245-3247.
|
10. |
Cooper M,Deering KL,Slakey DP,et al.Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.Transplantation,2009,88(4):514-520.
|
11. |
Sollinger HW,Sundberg AK,Leverson G,et al.Mycophenolate mofetil versus enteric-coated mycophenolate sodium:a large single-center comparison of dose adjustments and outcomes in kidney transplant recipients.Transplantation,2010,89(4):446-451.
|
12. |
Gozdowska J,Urbanowicz A,Baczkowska T,et al.Safety and tolerance of sodium mycophenolate in patients after renal transplantation-an observational study.Transplant Proc,2009,41(8):3016-3018.
|
13. |
Hardinger KL.Hebbar S,Bloomer T,et al.Adverse drug reaction driven immunosuppressive drug manipulations:A single-center comparison of enteric-coated mycophenolate sodium vs.mycophenolate mofetil.Clin Transplant,2008,22(5):555-561.
|
14. |
Salvadori M,Holzer H,de Mattos A,et al.Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.Am J Transplant,2004,4(2):231-236.
|
15. |
Pelletier RP,Henry ML,Rajab A,et al.Clinical outcomes of renal transplant recipients treated with enteric-coated mycophenolic acid vs mycophenolate mofetil as a swith agent using a primary steroid-free rapamune and microemulsion cyclosporine protocol.Clin Transplant,2007,21(21):532-535.
|
16. |
Pocivalnik M,Kirsch AH,Hassler EM,et al.Fever and pneumonitis induced by enteric-coated mycophenolate sodium in a patient after kidney transplantation.Transplant International,2013,26(7):e54-e57.
|
17. |
Loock J,Lamprecht P,Gross WL.Acute inflammatory syndrome with elevated procalcitonin induced by mycophenolate sodium.J Rheumatol,2012,39(3):658-659.
|
18. |
Maes B,Oellerich M,Ceuppens JL,et al.A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis.Nephrol Dial Transplant,2002,17(5):923-926.
|
19. |
Hochegger K,Gruber J,Lhotta K.Acute inflammatory syndrome induced by mycophenolate mofetil in a patient following kidney transplantation.Am J Transplant,2006,6(4):852-854.
|
20. |
Budde K,Bauer S,Hambach P,et al.Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients.Am J Transplant,2007,7(4):888-898.
|
21. |
阮钧,徐卓群,胡礼炳,等.肾移植术后肺炎的诊断和治疗.江苏医药,2006,32(8):794.
|